SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:24:57+00:00 February 6th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

HTHT [China Lodging,] CORRESP: (Original Filing)

[February6, 2012 VIA EDGAR STYLE="font-family:Times New Roman" SIZE="2"> Division ofrporation Finance 100 F Street, N.E. Mail Stop 3010 Attention: Kevin Woody, Branch Chief Howard Efron, Senior Staff Accountant Re: China Lodging, Limited Form 20-F for the year ended December31, 2010 filed on April7, 2011 (File No.1-34656) Dear Mr.Woody and Mr.Efron,]

By | 2016-02-07T11:47:17+00:00 February 6th, 2012|Categories: Chinese Stocks, HTHT, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:26:07+00:00 February 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

HTHT [China Lodging,] CORRESP: February6, 2012 VIA EDGAR STYLE=”font-family:Times New Roman” SIZE=”2″>

[February6, 2012 VIA EDGAR STYLE="font-family:Times New Roman" SIZE="2"> Division ofrporation Finance 100 F Street, N.E. Mail Stop 3010 Attention: Kevin Woody, Branch Chief Howard Efron, Senior Staff Accountant Re: China Lodging, Limited Form 20-F for the year ended December31, 2010 filed on April7, 2011 (File No.1-34656) Dear Mr.Woody and Mr.Efron,]

By | 2016-02-07T11:47:50+00:00 February 6th, 2012|Categories: Chinese Stocks, HTHT, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar